Myriad (MYGN) Issues Response to Supreme Court Decision on Gene Patent
Go back to Myriad (MYGN) Issues Response to Supreme Court Decision on Gene Patent| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.08 +0.21 (7.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.87 | 52 Week High | $45.34 | |||
| Open | $2.95 | 52 Week Low | $15.92 | |||
| Day High | $3.11 | P/E | 1.32 | |||
| Day Low | $2.92 | EPS | $2.33 | |||
| Volume | 1,311,255 | |||||
